Copyright
©2010 Baishideng.
World J Gastroenterol. Jan 14, 2010; 16(2): 193-200
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.193
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.193
Figure 1 Hepatopoietin Cn (HPPCn) acting as an autocrine factor for hepatocellular carcinoma (HCC) cells in vitro.
A: Immunohistochemistry showing staining with anti-HPPCn antibody in primarily cultured hepatocytes and HCC cells; B: Western blotting and enzyme-linked immunosorbent assay (ELISA) showing the secretion of HPPCn into culture medium (CM) of HCC-derived cells; C: ELISA showing the kinetics of HPPCn secretion from HCC cells; D: Binding of HPPCn to HCC cells.
- Citation: Chang J, Liu Y, Zhang DD, Zhang DJ, Wu CT, Wang LS, Cui CP. Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1. World J Gastroenterol 2010; 16(2): 193-200
- URL: https://www.wjgnet.com/1007-9327/full/v16/i2/193.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i2.193